TendoNova Inks Partnership with AcCELLerated Biologics ATLANTA, March 08, 2023 (GLOBE NEWSWIRE) -- TendoNova, an emerging leader in micro-invasive sports medicine procedures, is pleased to announce that it has reached an agreement with AcCELLerated...

TendoNova Receives GRA Phase III Commercialization Funding ATLANTA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- TendoNova Corporation is pleased to announce that it has been selected for the Georgia Research Alliance (GRA) Phase III commercialization program. The...

TendoNova Appoints Mark A. Samuels as CEO ATLANTA, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Atlanta-based TendoNova Corporation is pleased to announce the appointment of Mark A. Samuels as Chief Executive Officer effective September 9th, 2020. Mr....

NFLPA Invests in TendoNova to Develop Devices that Enable Microinvasive Orthopedic Procedures ATLANTA, June 11, 2020 (GLOBE NEWSWIRE) -- The NFL Players Association (NFLPA), through its for-profit subsidiary NFL Players Inc., has invested in TendoNova™ Corporation. TendoNova is an...

TendoNova Presents on the National Stage at NFL ‘1st and Future’ ATLANTA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- TendoNova™ Corporation was one of just five companies chosen to present on the national stage as a finalist for the 2019 NFL’s “1st and Future” competition...